Contradictory, García-Tobilla et al. 20 did not find significantly different expression levels of SFRP4 between normal and prostate cancer tissue, however, this study suffered from small sample size (normal n = 4, cancer n = 11). This evidence concerns the gene SFRP4 and prostate carcinoma.